Insider Transactions in Q2 2024 at Acadia Pharmaceuticals Inc (ACAD)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
975
-2.74%
|
$13,650
$14.79 P/Share
|
|
Jun 08
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,893
+5.06%
|
-
|
|
May 29
2024
|
Laura Brege |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+24.82%
|
-
|
|
May 29
2024
|
Daniel B Soland |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+16.1%
|
-
|
|
May 29
2024
|
Edmund Harrigan |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+20.59%
|
-
|
|
May 29
2024
|
James M Daly |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+21.25%
|
-
|
|
May 29
2024
|
Elizabeth A. Garofalo |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+22.81%
|
-
|
|
May 29
2024
|
Adora Ndu |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+37.61%
|
-
|
|
May 29
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
37,548
+0.28%
|
-
|
|
May 02
2024
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
11,427
-6.86%
|
$182,832
$16.94 P/Share
|
|
May 02
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,326
-8.45%
|
$21,216
$16.94 P/Share
|
|
May 02
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
SELL
Open market or private sale
|
Direct |
3,477
-7.62%
|
$55,632
$16.94 P/Share
|
|
May 02
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,503
-9.85%
|
$56,048
$16.94 P/Share
|
|
May 01
2024
|
Stephen Davis CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,391
+11.84%
|
-
|
|
May 01
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,596
+14.19%
|
-
|
|
May 01
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,814
+13.0%
|
-
|
|
May 01
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,814
+16.08%
|
-
|
|
Apr 08
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,716
-8.63%
|
$46,172
$17.87 P/Share
|
|
Apr 08
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,790
-6.2%
|
$30,430
$17.87 P/Share
|
|
Apr 08
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
SELL
Open market or private sale
|
Direct |
2,568
-6.21%
|
$43,656
$17.87 P/Share
|
|
Apr 08
2024
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
26,574
-8.06%
|
$451,758
$17.87 P/Share
|
|
Apr 07
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,489
+9.09%
|
-
|
|
Apr 05
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,275
+14.36%
|
-
|
|
Apr 05
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,010
+13.04%
|
-
|
|
Apr 05
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
BUY
Exercise of conversion of derivative security
|
Direct |
5,024
+10.83%
|
-
|
|
Apr 05
2024
|
Stephen Davis CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
51,999
+14.08%
|
-
|